Clinical Trial Update: Gemcitabine Plus Albumin-bound Paclitaxel In Patients With Advanced Metastatic Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for gemcitabine plus albumin-bound paclitaxel in patients with advanced metastatic pancreatic cancer (Phase 1/Phase 2; completed; results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Albumin-bound paclitaxel (nab-paclitaxel)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Celgene | Conditions: Metastatic Pancreatic Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2013-08-21